S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
S&P 500   4,140.06 (-0.12%)
DOW   32,832.54 (+0.09%)
QQQ   320.71 (-0.32%)
AAPL   164.87 (-0.29%)
MSFT   280.32 (-0.92%)
META   170.25 (+1.88%)
GOOGL   117.30 (-0.14%)
AMZN   139.41 (-0.99%)
TSLA   871.27 (+0.78%)
NVDA   177.93 (-6.30%)
NIO   20.17 (-0.25%)
BABA   90.84 (-1.86%)
AMD   100.07 (-2.19%)
MU   61.45 (-1.62%)
T   18.00 (-1.91%)
CGC   3.28 (+21.48%)
GE   75.18 (+1.10%)
F   15.78 (+3.14%)
DIS   109.11 (+2.33%)
AMC   23.96 (+8.03%)
PYPL   96.26 (+0.99%)
PFE   49.57 (+0.61%)
NFLX   233.49 (+2.96%)
NASDAQ:CLXT

Calyxt - CLXT Stock Forecast, Price & News

$0.30
+0.01 (+3.45%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.29
$0.33
50-Day Range
$0.21
$0.34
52-Week Range
$0.20
$4.43
Volume
585,590 shs
Average Volume
840,210 shs
Market Capitalization
$12.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Calyxt MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
2,233.3% Upside
$7.00 Price Target
Short Interest
Healthy
0.33% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.35mentions of Calyxt in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.56) to ($0.40) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.27 out of 5 stars

Medical Sector

371st out of 1,293 stocks

Agricultural Chemicals Industry

8th out of 13 stocks

CLXT stock logo

About Calyxt (NASDAQ:CLXT) Stock

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Calyxt Trading Up 8.6 %

Shares of CLXT traded up $0.02 during trading hours on Monday, hitting $0.31. The company had a trading volume of 6,440 shares, compared to its average volume of 836,349. Calyxt has a 52-week low of $0.20 and a 52-week high of $4.43. The company has a quick ratio of 1.99, a current ratio of 1.99 and a debt-to-equity ratio of 0.01. The stock's 50 day moving average price is $0.28 and its 200 day moving average price is $0.71.

Calyxt (NASDAQ:CLXT - Get Rating) last posted its quarterly earnings data on Thursday, May 5th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.04. Calyxt had a negative return on equity of 193.30% and a negative net margin of 229.78%. The business had revenue of $0.03 million for the quarter, compared to analysts' expectations of $0.85 million. During the same period in the previous year, the firm posted ($0.24) EPS. On average, research analysts predict that Calyxt will post -0.56 earnings per share for the current year.

Receive CLXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calyxt and its competitors with MarketBeat's FREE daily newsletter.

CLXT Stock News Headlines

Calyxt Q2 2022 Earnings Preview - Seeking Alpha
Calyxt (CLXT) Scheduled to Post Earnings on Thursday
Calyxt, Inc. (NASDAQ:CLXT) Short Interest Down 58.6% in June
Calyxt to Present at Upcoming Conferences
Calyxt Q1 2022 Earnings Preview
Calyxt Inc - Stock Ownership CLXT
Calyxt's Return On Capital Employed Overview
See More Headlines
Receive CLXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calyxt and its competitors with MarketBeat's FREE daily newsletter.

CLXT Company Calendar

Last Earnings
11/04/2021
Today
8/08/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CLXT
Fax
N/A
Employees
55
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.00
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+2,233.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-29,200,000.00
Net Margins
-229.78%
Pretax Margin
-114.68%

Debt

Sales & Book Value

Annual Sales
$25.99 million
Book Value
$0.37 per share

Miscellaneous

Free Float
41,827,000
Market Cap
$12.83 million
Optionable
Not Optionable
Beta
2.03

Key Executives














CLXT Stock - Frequently Asked Questions

Should I buy or sell Calyxt stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CLXT shares.
View CLXT analyst ratings
or view top-rated stocks.

What is Calyxt's stock price forecast for 2022?

2 equities research analysts have issued 12-month price targets for Calyxt's stock. Their CLXT stock forecasts range from $4.00 to $10.00. On average, they predict the company's share price to reach $7.00 in the next year. This suggests a possible upside of 2,258.5% from the stock's current price.
View analysts price targets for CLXT
or view top-rated stocks among Wall Street analysts.

How has Calyxt's stock performed in 2022?

Calyxt's stock was trading at $2.13 at the start of the year. Since then, CLXT stock has decreased by 86.1% and is now trading at $0.2968.
View the best growth stocks for 2022 here
.

When is Calyxt's next earnings date?

Calyxt is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our CLXT earnings forecast
.

How were Calyxt's earnings last quarter?

Calyxt, Inc. (NASDAQ:CLXT) posted its quarterly earnings results on Thursday, November, 4th. The company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.19) by $0.05. The business earned $7.76 million during the quarter, compared to the consensus estimate of $4.58 million. Calyxt had a negative net margin of 229.78% and a negative trailing twelve-month return on equity of 193.30%. During the same quarter in the previous year, the firm earned ($0.28) EPS.

What other stocks do shareholders of Calyxt own?

When did Calyxt IPO?

(CLXT) raised $101 million in an initial public offering (IPO) on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

How do I buy shares of Calyxt?

Shares of CLXT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $0.30.

How much money does Calyxt make?

Calyxt (NASDAQ:CLXT) has a market capitalization of $12.69 million and generates $25.99 million in revenue each year. The company earns $-29,200,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis.

How many employees does Calyxt have?

Calyxt employs 55 workers across the globe.

How can I contact Calyxt?

Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The official website for the company is www.calyxt.com. The company can be reached via phone at (651) 683-2807 or via email at clxt@mzgroup.us.

This page (NASDAQ:CLXT) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.